Literature DB >> 32637994

Understanding Patient-Based Real-Time Quality Control Using Simulation Modeling.

Andreas Bietenbeck1, Mark A Cervinski2,3, Alex Katayev4, Tze Ping Loh5, Huub H van Rossum6,7, Tony Badrick8.   

Abstract

BACKGROUND: Patient-based real-time quality control (PBRTQC) avoids limitations of traditional quality control methods based on the measurement of stabilized control samples. However, PBRTQC needs to be adapted to the individual laboratories with parameters such as algorithm, truncation, block size, and control limit.
METHODS: In a computer simulation, biases were added to real patient results of 10 analytes with diverse properties. Different PBRTQC methods were assessed on their ability to detect these biases early.
RESULTS: The simulation based on 460 000 historical patient measurements for each analyte revealed several recommendations for PBRTQC. Control limit calculation with "percentiles of daily extremes" led to effective limits and allowed specification of the percentage of days with false alarms. However, changes in measurement distribution easily increased false alarms. Box-Cox but not logarithmic transformation improved error detection. Winsorization of outlying values often led to a better performance than simple outlier removal. For medians and Harrell-Davis 50 percentile estimators (HD50s), no truncation was necessary. Block size influenced medians substantially and HD50s to a lesser extent. Conversely, a change of truncation limits affected means and exponentially moving averages more than a change of block sizes. A large spread of patient measurements impeded error detection. PBRTQC methods were not always able to detect an allowable bias within the simulated 1000 erroneous measurements. A web application was developed to estimate PBRTQC performance.
CONCLUSIONS: Computer simulations can optimize PBRTQC but some parameters are generally superior and can be taken as default. © American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  average of normals; exponentially weighted moving average; moving average; optimization; quality control; simulation

Year:  2020        PMID: 32637994     DOI: 10.1093/clinchem/hvaa094

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Impact of combining data from multiple instruments on performance of patient-based real-time quality control.

Authors:  Qianqian Zhou; Tze Ping Loh; Tony Badrick; Chun Yee Lim
Journal:  Biochem Med (Zagreb)       Date:  2021-04-15       Impact factor: 2.313

2.  Intelligent Quality Management 2 with IntraSpect™ technology for quality control of GEM® Premier™ 5000 blood gas analyzers- A novel application of the patient sample as its own control.

Authors:  James O Westgard; Jose Cervera
Journal:  Pract Lab Med       Date:  2022-04-08

3.  A study of the moving rate of positive results for use in a patient-based real-time quality control program on a procalcitonin point-of-care testing analyzer.

Authors:  Yili He; Daqing Gu; Xiangzhi Kong; Zhiqiang Feng; Weishang Lin; Yunfeng Cai
Journal:  J Clin Lab Anal       Date:  2022-03-07       Impact factor: 2.352

4.  A study on quality control using delta data with machine learning technique.

Authors:  Yufang Liang; Zhe Wang; Dawei Huang; Wei Wang; Xiang Feng; Zewen Han; Biao Song; Qingtao Wang; Rui Zhou
Journal:  Heliyon       Date:  2022-07-14

5.  Assessment of patient based real-time quality control on comparative assays for common clinical analytes.

Authors:  Yide Lu; Fan Yang; Dongmei Wen; Kaifeng Shi; Zhichao Gu; Qiuya Lu; Xuefeng Wang; Danfeng Dong
Journal:  J Clin Lab Anal       Date:  2022-08-10       Impact factor: 3.124

6.  Comparison and optimization of various moving patient-based real-time quality control procedures for serum sodium.

Authors:  Yuanyuan Li; Qian Yu; Xiaoyan Zhang; Xiaoling Chen
Journal:  J Clin Lab Anal       Date:  2021-09-14       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.